07:00 , May 17, 2004 |  BioCentury  |  Finance

U.S. investment in Europe

U.S. investment in Europe Company Country Raised (M) Investors Speedel Switzerland $57.6 Novartis; DSM Venturing Intercell Austria $50.0 Global Life Science Ventures; Apax Partners; Nomura International; TVM Techno Venture Management; NIB; Star Ventures; MPM Capital...
07:00 , Aug 19, 2002 |  BioCentury  |  Emerging Company Profile

Corporate Profile

MerLion Pharmaceuticals Pte. Ltd. Singapore Technology: Drug discovery from natural products Disease focus: NA Clinical status: Preclinical Founded: 2002 by the Centre for Natural Product Research Corporate partners: GlaxoSmithKline plc ; Fujisawa Pharmaceutical Co. Ltd....